fluticasone-propionate--salmeterol-xinafoate-drug-combination and Attention-Deficit-Disorder-with-Hyperactivity

fluticasone-propionate--salmeterol-xinafoate-drug-combination has been researched along with Attention-Deficit-Disorder-with-Hyperactivity* in 2 studies

Reviews

1 review(s) available for fluticasone-propionate--salmeterol-xinafoate-drug-combination and Attention-Deficit-Disorder-with-Hyperactivity

ArticleYear
What's new: newly approved drugs for children.
    Pediatrics in review, 2001, Volume: 22, Issue:10

    Topics: Adolescent; Age Factors; Albuterol; Androstadienes; Anticonvulsants; Asthma; Atovaquone; Attention Deficit Disorder with Hyperactivity; Beclomethasone; Carbamazepine; Child; Delayed-Action Preparations; Diabetes Mellitus, Type 1; Drug Approval; Drug Combinations; Drug Delivery Systems; Drug Therapy; Epilepsies, Partial; Fluticasone-Salmeterol Drug Combination; HIV Protease Inhibitors; Humans; Insulin; Insulin Glargine; Insulin, Long-Acting; Lopinavir; Methylphenidate; Naphthoquinones; Nebulizers and Vaporizers; Oxcarbazepine; Pediatrics; Proguanil; Pyrimidinones; Ritonavir; United States

2001

Other Studies

1 other study(ies) available for fluticasone-propionate--salmeterol-xinafoate-drug-combination and Attention-Deficit-Disorder-with-Hyperactivity

ArticleYear
Brief Psychotic Episode Caused by Advair Diskus in a Pediatric Patient.
    The primary care companion for CNS disorders, 2017, May-11, Volume: 19, Issue:3

    Topics: Adolescent; Attention Deficit Disorder with Hyperactivity; Diagnosis, Differential; Drug Substitution; Fluticasone-Salmeterol Drug Combination; Hospitalization; Humans; Male; Psychoses, Substance-Induced; Sympathomimetics

2017